Endometrioid Adenocarcinoma after Insertion of a Levonorgestrel-releasing Intrauterine System

Journal of Minimally Invasive Gynecology

Volumn 15, Issue 6, 2008, Pages 771-773

  Flemming, Rhonda ^a   Sathiyathasan, Sahathevan ^a   Jackson, Anne ^a  

^a CHASE FARM HOSPITAL   (United Kingdom)

Author keywords

Adenocarcinoma; Levonorgestrel releasing intrauterine system; Menorrhagia

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ADULT; ANAMNESIS; ARTICLE; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA;

ADULT; CARCINOMA, ENDOMETRIOID; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; INTRAUTERINE DEVICES; LEVONORGESTREL; MAGNETIC RESONANCE IMAGING; MENORRHAGIA; OVARIECTOMY; SALPINGOSTOMY;

EID: 54349105362     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2008.08.016     Document Type: Article

References (14)

1. Dhar K.K., Needhirajan T., Koslowski M., et al. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol 97 (2005) 924-927
2. Riphagen F. Intrauterine application of progestins in hormone replacement therapy: a review. Climacteric 3 (2000) 199-211
3. Curtis K.M., and Marchbanks P.A. Neoplasia with use of intrauterine devices. Contraception 75 6 Suppl (2007 June) S60-S69
4. Phillips V., Graham C.T., and Manek S. The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J Clin Pathol 56 (2003) 305-307
5. Anderson J.K., and Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 97 (1990) 670-694
6. Norris H.J., Tavassoli F.A., and Kurman R.J. Endometrial hyperplasia and carcinoma: diagnostic consideration. Am J Surg Pathol 7 (1983) 839-847
7. Thomas C., Randall M.D., Robert J., and Kurman M.D. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90 (1997) 434-440
8. Giannopoulos T., Butler-Manuel S., and Tailor A. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol Oncol 95 (2004) 762-764
9. Jones K., Georgiou M., Hyatt D., et al. Endometrial adenocarcinoma following the insertion of a Mirena IUCD. Gynecol Oncol 87 (2002) 216-218
10. Abu J., Brown L., and Ireland D. Endometrial adenocarcinoma following insertion of the levonorgestrel-releasing intrauterine system (Mirena) in a 36-year-old woman. Int J Gynecol Cancer 16 (2006) 1445-1447
11. Ndumbe F.M., and Husemeyer R. Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena®). J Fam Plann Reprod Health Care 32 2 (2006) 113-114
12. Clark T., Khan K., and Gupta J. Current practice in the treatment of benign intrauterine polyps: a national questionnaire survey of consultant gynecologist in the UK. Eur J Obstet Gynaecol Reprod Biol 103 (2002) 65-67
13. Vorgias G., Lekka J., Katsoulis M., et al. Diagnostic accuracy of prehysterectomy curettage in determining tumor type and grade in patients with endometrial cancer. MedGenMed 4 (2003) 7
14. Silverberg S.G., Makowski E.L., and Roche W.D. Endometrial carcinoma in women under 40 years of age: comparison of cases in oral contraceptive users and non-users. Cancer 39 (1977) 592-598